Aurobindo Pharma Ltd — Ritonavir Exporter Profile
Indian Pharmaceutical Exporter · #5 for Ritonavir · $4.9M export value · DGFT Verified
Aurobindo Pharma Ltd is the #5 Indian exporter of Ritonavir with $4.9M in export value and 104 verified shipments. Aurobindo Pharma Ltd holds a 6.3% market share in Ritonavir exports across 39 countries.
Aurobindo Pharma Ltd — Ritonavir Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Ltd Export Ritonavir?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MYANMAR | $545.6K | 14 | 18.6% |
| MOZAMBIQUE | $271.0K | 6 | 9.3% |
| ETHIOPIA | $261.9K | 7 | 8.9% |
| MALAYSIA | $251.5K | 7 | 8.6% |
| GABON | $195.1K | 8 | 6.7% |
| COLOMBIA | $150.0K | 3 | 5.1% |
| KENYA | $139.0K | 5 | 4.8% |
| LIBERIA | $112.5K | 3 | 3.8% |
| FRANCE | $85.4K | 9 | 2.9% |
| CENTRAL AFRICAN REPUBLIC | $74.2K | 2 | 2.5% |
Aurobindo Pharma Ltd exports Ritonavir to 55 countries. The largest destination is MYANMAR accounting for 18.6% of Aurobindo Pharma Ltd's Ritonavir shipments, followed by MOZAMBIQUE (9.3%) and ETHIOPIA (8.9%). These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ritonavir from Aurobindo Pharma Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UNITED NATIONS OFFICE FOR PROJECT | MYANMAR | $295.6K | 9 |
| UNIMED SDN BHD | MALAYSIA | $201.2K | 5 |
| OFFICE PHARMACEUTIQUE NATIONAL | GABON | $195.1K | 8 |
| MINISTERIO DA SAUDE/CENTRAL DE | MOZAMBIQUE | $150.0K | 3 |
| UNITED NATIONS OFFICE FOR PROJECT S ERVICES PRINCIPAL | MYANMAR | $150.0K | 3 |
| THE MINISTRY OF HEALTH SOCIAL | LIBERIA | $112.5K | 3 |
| COMMERCIAL BANK | ETHIOPIA | $111.9K | 4 |
| MINISTRY OF HEALTH | MALAWI | $104.1K | 10 |
| KENYA MEDICAL SUPPLIES AGENCY | KENYA | $100.9K | 4 |
| ETHIOPIAN PHARMACEUTICALS FUND AND | ETHIOPIA | $100.0K | 2 |
Aurobindo Pharma Ltd supplies Ritonavir to 77 buyers globally. The largest buyer is UNITED NATIONS OFFICE FOR PROJECT (MYANMAR), followed by UNIMED SDN BHD (MALAYSIA) and OFFICE PHARMACEUTIQUE NATIONAL (GABON). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ritonavir Export Value and How Much Does Aurobindo Pharma Ltd Contribute?
India exported $69.2M worth of Ritonavir through 1,555 shipments from 84 suppliers to 155 countries, serving 525 buyers globally. Aurobindo Pharma Ltd contributes $4.9M to this total, accounting for 6.3% of India's Ritonavir exports. Aurobindo Pharma Ltd ships Ritonavir to 55 countries through 77 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Ltd's Ritonavir Exports?
Aurobindo Pharma Ltd's average Ritonavir shipment value is $47.0K per consignment, based on 104 shipments totaling $4.9M. The largest destination is MYANMAR (18.6% of Aurobindo Pharma Ltd's Ritonavir exports).
How Does Aurobindo Pharma Ltd Compare to Other Indian Ritonavir Exporters?
Aurobindo Pharma Ltd ranks #5 among 84 Indian Ritonavir exporters with a 6.3% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($27.5M), HETERO LABS LIMITED ($24.7M), EMCURE PHARMACEUTICALS LIMITED ($5.5M). Aurobindo Pharma Ltd processed 104 shipments to 39 destination countries.
What Ritonavir Formulations Does Aurobindo Pharma Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LOPINAVIR AND RITONAVIR TABLETS 200 & 50 | $498.5K | 19 |
| LOPINAVIR AND RITONAVIR TABLETS 200 & 50MG (HIVUS-LR 200/50) 120S (QTY:10260PAK)NOS | $150.0K | 3 |
| LOPINAVIR AND RITONAVIR TABLETS 200 & 50MG (LOPINAVIR AND RITONAVIR TABLETS USP200 / 50 mg) 120'S | $147.3K | 3 |
| LOPINAVIR/RITONAVIR TABLETS 100 /25MG 60 | $134.4K | 9 |
| LOPINAVIR AND RITONAVIR TABLETS USP 100M | $100.9K | 4 |
| LOPINAVIR AND RITONAVIR TABLETS 200 & 50MG LOPINAVIR AND RITONAVIR TABLETS USP 200 / 50 mg 120'S 29917 Packs | $100.0K | 2 |
| LOPINAVIR AND RITONAVIR TABLETS 200 & 50MG, 23149 PACKS OF 120'S(AS PER INVOICE) | $100.0K | 2 |
| LOPINAVIR/RITONAVIR TABLETS 100 /25MG(LO | $79.9K | 4 |
| LOPINAVIR AND RITONAVIR TABLETS 200 & 50MG (LOPINAVIR AND RITONAVIR TABLETS USP 200 / 50 mg | $71.0K | 2 |
| LOPINAVIR/RITONAVIR TABLETS 100 /25MG (L | $70.7K | 10 |
Aurobindo Pharma Ltd exports 82 distinct Ritonavir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LOPINAVIR AND RITONAVIR TABLETS 200 & 50 with 19 shipments worth $498.5K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Aurobindo Pharma Ltd Compare to Nearest Ritonavir Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | HETERO LABS LIMITED | $24.7M | 494 | 81 | $50.0K |
| 4 | EMCURE PHARMACEUTICALS LIMITED | $5.5M | 110 | 43 | $50.0K |
| 5 | AUROBINDO PHARMA LTD ★ | $4.9M | 104 | 39 | $47.0K |
| 7 | AUROBINDO PHARMA LIMITED | $2.1M | 43 | 26 | $50.0K |
| 8 | MACLEODS PHARMACEUTICALS LTD | $1.8M | 36 | 11 | $50.0K |
Aurobindo Pharma Ltd ranks #5 among 84 Indian Ritonavir exporters. Average shipment value of $47.0K compared to the market average of $823.4K. The closest competitors by value are HETERO LABS LIMITED and EMCURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Ritonavir Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 335 | 21.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 281 | 18.1% |
| HYDERABAD ACC (INHYD4) | 217 | 14.0% |
| HYDERABAD AIR | 123 | 7.9% |
| Bombay Air | 87 | 5.6% |
| NHAVA SHEVA SEA (INNSA1) | 58 | 3.7% |
| DELHI AIR CARGO ACC (INDEL4) | 48 | 3.1% |
| HYDERABAD ICD | 47 | 3.0% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ritonavir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ritonavir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 147 individual customs records matching Aurobindo Pharma Ltd exporting Ritonavir, covering 82 formulations to 55 countries via 77 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 155+ countries, 525+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ritonavir Export Data from Aurobindo Pharma Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Ritonavir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Ritonavir Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ritonavir. For current shipment-level data, contact TransData Nexus.